Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment

被引:5
|
作者
Cerdán, LF
Guevara, MA
Sanz, A
Amezcua, C
Ramos-Loyo, J
机构
[1] Inst Mexicano Seguro Social, Ctr Comunitario Salud Mental 1, Mexico City, DF, Mexico
[2] Univ Guadalajara, Inst Neurociencias, Guadalajara, Jalisco, Mexico
关键词
atypical neuroleptics; coherent activity; EEG; olanzapine; treatment refractory schizophrenia;
D O I
10.1016/j.ijpsycho.2004.12.008
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The aim of the present study was to identify brain electrical activity changes generated by olanzapine (OLZ) in treatment refractory schizophrenics (TRS). 14 paranoid TRS (31.5 +/- 8.39 years old) were evaluated before and after 8 weeks of OLZ treatment. Psychopathology was evaluated by means of total BPRS and PANSS scores. Resting EEG was recorded in the pre (under typical neuroleptics) and post (under OLZ) sessions. A good response to OLZ was observed in 57% of TRS. A significant reduction in positive and negative symptoms scales of PANSS was found. Absolute power of theta1, theta2, alpha1 bands increased after treatment, while beta2 power showed a decrease. Intrahemispheric correlation increased between different zones of the frontal areas and between frontal and posterior areas, while interhemispheric correlation decreased in theta2. EEG changes were more evident in those patients who had a better response to OLZ. OLZ showed to be effective in TRS, improving psychiatric symptoms and increasing activity synchronization between different areas within each hemisphere that may indicate a functional reorganization, particularly in good responders. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 50 条
  • [21] Changes in regional brain activity in major depression after successful treatment with antidepressant drugs
    Ogura, A
    Morinobu, S
    Kawakatsu, S
    Totsuka, S
    Komatani, A
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1998, 98 (01) : 54 - 59
  • [22] An open trial of olanzapine in patients with treatment-refractory psychoses
    Sanders, RD
    Mossman, D
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) : 62 - 66
  • [23] Olanzapine in the Treatment of Refractory Nausea and Vomiting in Palliative Care Settings
    Gupta, Nishkarsh
    Puri, Sidharth
    Kumar, Vinod
    Garg, Rakesh
    Bharati, Sachidanand Jee
    Mishra, Seema
    Bhatnagar, Sushma
    [J]. INDIAN JOURNAL OF PALLIATIVE CARE, 2018, 24 (03) : 372 - 374
  • [24] High-dose olanzapine for treatment-refractory schizophrenia
    Sheitman, BB
    Lindgren, JC
    Early, J
    Sved, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (11): : 1626 - 1626
  • [25] High-dose olanzapine for treatment-refractory schizophrenia
    Lerner, V
    [J]. CLINICAL NEUROPHARMACOLOGY, 2003, 26 (02) : 58 - 61
  • [26] Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain
    Agostinho, Fabiano R.
    Reus, Gislaine Z.
    Stringari, Roberto B.
    Ribeiro, Karine F.
    Ferreira, Gabriela K.
    Jeremias, Isabela C.
    Scaini, Giselli
    Rezin, Gislaine T.
    Streck, Emilio L.
    Quevedo, Joao
    [J]. ACTA NEUROPSYCHIATRICA, 2011, 23 (06): : 282 - 291
  • [27] INCREASED PLATELET PHOSPHOLIPASE-A2 ACTIVITY IN SCHIZOPHRENICS AND REDUCTION AFTER NEUROLEPTIC TREATMENT
    MARAS, A
    STEUDLE, A
    GATTAZ, WF
    [J]. SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 123 - 123
  • [28] Olanzapine treatment after clozapine induced agranulocytosis
    Lokshin, P
    Dorfman, P
    Shoshani, D
    Wimmer, P
    Dossenbach, M
    Belmaker, RH
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (08) : 583 - 584
  • [29] Changes on subjective estimates of sleep after 6 weeks treatment with olanzapine in acute mania
    Yoon, B.
    Bahk, W-M.
    Jon, D-I.
    Lee, S-Y.
    Lee, J-G.
    Won, S-H.
    Seo, J-S.
    Min, K-J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 340 - 340
  • [30] Neurocognitive function after treatment with lithium or olanzapine
    Yurgelun-Todd, D
    Gruber, S
    Risser, R
    Briggs, S
    Schoenberger, E
    Tohen, M
    [J]. ANNALS OF NEUROLOGY, 2005, 58 : S32 - S33